Comparison of change in lipoprotein(a) mass and molar concentrations by alirocumab and risk of subsequent cardiovascular events in ODYSSEY OUTCOMES

  • Michael Szarek
  • , Esther Reijnders
  • , Ph Gabriel Steg
  • , J. Wouter Jukema
  • , Markus Schwertfeger
  • , Deepak L. Bhatt
  • , Vera A. Bittner
  • , Rafael Diaz
  • , Sergio Fazio
  • , Genevieve Garon
  • , Shaun G. Goodman
  • , Robert A. Harrington
  • , Harvey D. White
  • , Andreas M. Zeiher
  • , Christa Cobbaert
  • , Gregory G. Schwartz

Research output: Contribution to journalArticlepeer-review

4 Scopus citations
Original languageEnglish
Pages (from-to)e75-e78
JournalEuropean Journal of Preventive Cardiology
Volume31
Issue number10
DOIs
StatePublished - 1 Aug 2024
Externally publishedYes

Cite this